BioNTech WKN: A2PSR2 ISIN: US09075V1026 Forum: Aktien Thema: Hauptdiskussion

Was passiert morgen mit dem Kurs? Sehen wir wieder die 90?? Zumindest die nächsten Tage?

Woher habt ihr die Seiten 😂😂😂😂

https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-choose-lead-mrna-vaccine-candidate-against

Das klingt doch sauber. Eine der News, auf die wir gewartet hatten.

Yuhuuuuuuu

Hier der Link dazu

https://seekingalpha.com/news/3595592

Warst schneller als ich Markus 😃

Unsere Phase 3...

Pfizer, BioNTech rise as they start late-stage vaccine human trial Jul. 27, 2020 5:24 PM ETPfizer Inc. (PFE)By: Jason Aycock, SA News Editor Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have begun their late-stage human trials for their lead mRNA COVID-19 vaccine candidate. Pfizer is up 1.9% postmarket; BioNTech is up 6%. The candidate BNT162b2, a nucleoside-modified messenger RNA vaccine that encodes an optimized SARS-Cov-2 full-length spike glycoprotein, is starting a 2-dose regimen in a phase 2/3 safety/efficacy study. The study is worldwide, except for China. “Today, we are starting our late-stage global study, which will include up to 30,000 participants. We selected BNT162b2 as our lead candidate for this Phase 2/3 trial upon diligent evaluation of the totality of the data generated so far," says Pfizer's Head of Vaccine Research and Development Kathrin U. Jansen. Assuming clinical success, the companies claim they are on track to seek regulatory review as soon as October - and pending approval, to supply up to 100M doses by the end of 2020 (and 1.3B doses by the end of 2021).

https://www.pagina12.com.ar/281228-coronavirus-como-seran-los-ensayos-de-la-vacuna-en-argentina

Krass jaja 🤭🤭🙀

Wow, wo kommt das denn auf einmal her? 91$

Mef36 woher ?

Zieht Nachbörslich nochmal gut an

https://www.nasdaq.com/market-activity/stocks/bntx